Robert Schrepfer Insider Profile
11 Followers
Robert Schrepfer, SVP - NEW BUS DEV & SPEC SALES at ANI Pharmaceuticals, holds 87.48K shares in ANI Pharmaceuticals (Ticker: ANIP).
Robert Schrepfer's Trading History
| ANIPANI Pharmaceuticals | Mar 29, 2021 | SVP - NEW BUS DEV & SPEC SALES | Uninformative Sell | 181.90K | $6.25M | |
ANIP Insider Shares: 87.48K (0.71%) | ||||||
You May Also Like
Robert Schrepfer insider profile FAQ
What is the percentage of profitable transactions made by Robert Schrepfer?
The percentage of profitable transactions made by Robert Schrepfer is 50%.
What is the average return per transaction made by Robert Schrepfer?
The average return per transaction made by Robert Schrepfer is 18.10%.
What stocks does Robert Schrepfer hold?
Robert Schrepfer holds: ANIP stocks.
What was Robert Schrepfer’s latest transaction?
Robert Schrepfer’s latest transaction was an Uninformative Sell of $181.90K.
What was Robert Schrepfer's most profitable transaction?
Robert Schrepfer’s most profitable transaction was an Informative Sell of ANIP stock on May 13, 2019. The return on the trade was 55.80%.
What is Robert Schrepfer's role in ANI Pharmaceuticals?
Robert Schrepfer's role in ANI Pharmaceuticals is SVP - NEW BUS DEV & SPEC SALES.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
